The efficacy and tolerability of the slow-acting combined agent glucosamine and chondroitin sulfate in gonarthrosis patients tacking no nonsteroidal anti-inflammatory drugs
Objective: to evaluate the efficacy and tolerability of the combined symptomatic slow-acting combined agent Theraflex in gonarthrosis patients untreated with nonsteroidal antiinflammatory drugs (NSAIDs).Patients and methods. The investigation enrolled 84 patients (78 women and 6 men) aged 55.23±7.36...
Saved in:
| Main Authors: | A. P. Rebrov, I. A. Romanova, I. Z. Gaydukova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2016-01-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/654 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cardiovascular safety and efficacy of the combined symptomatic slow-acting drug glucosamine and chondroitin sulfate in patients with gonarthrosis
by: A. P. Rebrov, et al.
Published: (2016-06-01) -
Efficacy of combination chondroitin sulfate plus glucosamine hydrochloride in osteoarthritis: A systematic review
by: Anton V. Naumov, et al.
Published: (2024-12-01) -
Hepatoprotective effects of chondroitin sulfate and glucosamine sulfate
by: I. Yu. Torshin, et al.
Published: (2022-01-01) -
Multimorbidity in osteoarthritis and pleiotropic effects of slow-acting symptomatic drugs. Resolution of the multidisciplinary International Expert Council
by: V. I. Mazurov, et al.
Published: (2023-10-01) -
Russian experience with injectable chondroitin sulfate and glucosamine sulfate: a review of clinical trials
by: A. E. Karateev, et al.
Published: (2018-04-01)